Top Markets
Coin of the day
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Rang in aandelen #33956
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Aandeelprijs
$1.83
Laatst gesynchroniseerd: 2026-08-14
Marktkapitalisatie
$6.53M
Verandering (1 dag)
-1.61%
Verandering (1 jaar)
-85.57%
Land
US
Handel Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Categorie

Dividendrendementgeschiedenis voor Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Het dividendrendement (TTM) van Cadrenal Therapeutics, Inc. Common Stock (aandelsymbool: CVKD) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Cadrenal Therapeutics, Inc. Common Stock (CVKD) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten